Møller, M.W.; Andersen, M.S.; Halle, B.; Pedersen, C.B.; Boldt, H.B.; Tan, Q.; Jurmeister, P.S.; Herrgott, G.A.; Castro, A.V.; Petersen, J.K.;
et al. Genome-Wide DNA Methylation Profiling as a Prognostic Marker in Pituitary Adenomas—A Pilot Study. Cancers 2024, 16, 2210.
https://doi.org/10.3390/cancers16122210
AMA Style
Møller MW, Andersen MS, Halle B, Pedersen CB, Boldt HB, Tan Q, Jurmeister PS, Herrgott GA, Castro AV, Petersen JK,
et al. Genome-Wide DNA Methylation Profiling as a Prognostic Marker in Pituitary Adenomas—A Pilot Study. Cancers. 2024; 16(12):2210.
https://doi.org/10.3390/cancers16122210
Chicago/Turabian Style
Møller, Morten Winkler, Marianne Skovsager Andersen, Bo Halle, Christian Bonde Pedersen, Henning Bünsow Boldt, Qihua Tan, Philipp Sebastian Jurmeister, Grayson A. Herrgott, Ana Valeria Castro, Jeanette K. Petersen,
and et al. 2024. "Genome-Wide DNA Methylation Profiling as a Prognostic Marker in Pituitary Adenomas—A Pilot Study" Cancers 16, no. 12: 2210.
https://doi.org/10.3390/cancers16122210
APA Style
Møller, M. W., Andersen, M. S., Halle, B., Pedersen, C. B., Boldt, H. B., Tan, Q., Jurmeister, P. S., Herrgott, G. A., Castro, A. V., Petersen, J. K., & Poulsen, F. R.
(2024). Genome-Wide DNA Methylation Profiling as a Prognostic Marker in Pituitary Adenomas—A Pilot Study. Cancers, 16(12), 2210.
https://doi.org/10.3390/cancers16122210
